FDA PMA FDA Class 3 Approved 🇺🇸 United States

System, Endovascular Graft, Arteriovenous (Av) Dialysis Access Circuit Stenosis Treatment

PMA: P170042 · Supplement: S002 · Decision Mar 1, 2019
Classifications
1
FEI Numbers
14
Registration Numbers
14

Basic Information

Device Name
System, Endovascular Graft, Arteriovenous (Av) Dialysis Access Circuit Stenosis Treatment
Trade Name
Covera™ Vascular Covered Stent
PMA Number
P170042
Supplement Number
S002
Device Class
FDA Class 3
Product Code
PFV
Generic Name
System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
March 1, 2019
Date Received
September 4, 2018
Supplement Type
Panel Track
Supplement Reason
Labeling Change - Indications/instructions/shelf life/tradename
Expedited Review
N
Docket Number
19M-0995

Advisory Committee Statement

Approval of the COVERA Vascular Covered Stent. The device is indicated for use in hemodialysis patients for the treatment of stenoses in the venous outflow of an arterio-venous fistula and at the venous anastomosis of an ePTFE or other synthetic AV graft.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
PFV System, Endovascular Graft, Arteriovenous (Av) Dialysis Access Circuit Stenosis Treatment